Amylyx Pharmaceuticals, Inc. (AMLX)
NASDAQ: AMLX · Real-Time Price · USD
13.94
+0.95 (7.27%)
Feb 6, 2026, 2:19 PM EST - Market open
Amylyx Pharmaceuticals Market Cap
Amylyx Pharmaceuticals has a market cap or net worth of $1.53 billion as of February 6, 2026. Its market cap has increased by 545.91% in one year.
Market Cap
1.53B
Enterprise Value
1.18B
1-Year Change
545.91%
Ranking
Category
Stock Price
$13.94
Market Cap Chart
Since the IPO on January 7, 2022, Amylyx Pharmaceuticals's market cap has increased from $1.07B to $1.53B, an increase of 43.13%. That is a compound annual growth rate of 9.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 5, 2026 | 1.43B | 7.53% |
| Dec 31, 2025 | 1.33B | 415.49% |
| Dec 31, 2024 | 257.35M | -74.11% |
| Dec 29, 2023 | 993.86M | -59.40% |
| Dec 30, 2022 | 2.45B | 128.97% |
| Jan 7, 2022 | 1.07B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bausch Health Companies | 2.10B |
| Perrigo Company | 2.02B |
| Dynavax Technologies | 1.76B |
| Harrow | 1.75B |
| ANI Pharmaceuticals | 1.70B |
| Phibro Animal Health | 1.66B |
| Alvotech | 1.59B |
| BioCryst Pharmaceuticals | 1.59B |